Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Alzamend Neuro, Inc. (ALZN) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2026-04-30.
| Income Statement Financials | |
-- |
|
$-2.87M |
|
-- |
|
-- |
|
$2.87M |
|
$-2.87M |
|
$0.00M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.84M |
|
3.34M |
|
3.34M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$1.76M |
|
$0.31M |
|
$0.31M |
|
$2.08M |
|
$1.35M |
|
-- |
|
-- |
|
$1.35M |
|
$0.73M |
|
$0.73M |
|
$0.73M |
|
4.26M |
|
| Cash Flow Statement Financials | |
$-8.07M |
|
-- |
|
$4.83M |
|
$3.95M |
|
$0.71M |
|
$-3.24M |
|
$0.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.31 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-391.42% |
|
-391.42% |
|
-138.02% |
|
-391.42% |
|
$0.17 |
|
$-2.42 |
|
$-2.42 |
|